Evidence map›Paper›PMID 36353787›Full record

ArticleThe Korean journal of internal medicine2023

Recognition and attitudes of Korean physicians toward fecal microbiota transplantation: a survey study.

Tae-Geun Gweon, Yoo Jin Lee, Sung Kyun Yim, Seung Yong Kim, Chang Hwan Choi, Young-Seok Cho, Microbiome Research Group of the Korean Society for Neurogastroenterology and Motility

Open access · goldAbstract read
In one paragraph

Article in The Korean journal of internal medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Awareness and acceptability of gut microbiome transfer.Frontiers in gastroenterology (Lausanne, Switzerland) · 2024
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Tae-Geun GweonDepartment of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Yoo Jin LeeDepartment of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea.
Sung Kyun YimDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Korea.
Seung Yong KimDepartment of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.
Chang Hwan ChoiDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
Young-Seok ChoDepartment of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Microbiome Research Group of the Korean Society for Neurogastroenterology and Motility
Catholic University of Korea · KRChung-Ang University · KRJeonbuk National University · KRKeimyung University · KRKorea University · KR

Funding

Korea Health Industry Development InstituteMinistry of Health and Welfare HC20C0099Ministry of Health and Welfare HI19C0481Ministry of Science and ICTNational Research Foundation of Korea 2021R1G1A1094049
6 · The paper itself

Abstract

BACKGROUND/

aimsFecal microbiota transplantation (FMT) represents a treatment option for recurrent Clostridioides difficile infection (CDI). Recently, FMT has been investigated in various clinical settings other than CDI. This study examined Korean physicians' recognition of FMT and their attitudes toward this procedure.

methodsAn online questionnaire included questions on indications for FMT, the FMT process, physicians' attitudes toward FMT for the treatment of CDI and non-CDI diseases, and possible concerns.

resultsFinally, 107 physicians responded to this survey: 66 (61.7%) had experience of performing FMT, and 86 (80.4%) replied that they were willing to perform FMT for CDI. Two-thirds of physicians (63.6%, n = 68) would perform FMT for recurrent CDI on patients who had at least three recurrences. The most common obstacle to performing FMT for the treatment of CDI was the lack of regulations or guidelines (55.1%, n = 59). Seventy-seven (72.0%) physicians would consider FMT for non- CDI diseases when conventional treatment had failed. The most common obstacle for FMT for the treatment of non-CDI diseases was low treatment efficacy (57.0%, n = 61).

conclusionTwo-thirds of Korean physicians had experience of performing FMT, and many performed FMT for recurrent CDI. The results of this study will prove useful to researchers and practitioners in FMT in Korea.

Indexed as

Clostridioides difficileClostridium InfectionsPhysiciansFecal Microbiota TransplantationHumansRecurrenceRepublic of KoreaSurveys and QuestionnairesTreatment OutcomeClostridioides difficile infectionFecal microbiota transplantationSurveys and questionnaires

Identifiers

PMID36353787
PMCPMC9816678
OpenAlexW4308680000

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.